94 related articles for article (PubMed ID: 9615745)
1. 5-FU uptake in liver metastases after intravenous and intraperitoneal administration: an autoradiographic study in the rat.
Mahteme H; Larsson BS; Sundin A; Graf W
Anticancer Res; 1998; 18(2A):943-9. PubMed ID: 9615745
[TBL] [Abstract][Full Text] [Related]
2. 5-FU uptake in peritoneal metastases after pretreatment with radioimmunotherapy or vasoconstriction: an autoradiographic study in the rat.
Mahteme H; Sundin A; Larsson B; Khamis H; Arow K; Graf W
Anticancer Res; 2005; 25(2A):917-22. PubMed ID: 15868928
[TBL] [Abstract][Full Text] [Related]
3. Uptake of 5-fluorouracil (5-FU) in peritoneal metastases in relation to the route of drug administration and tumour debulking surgery. an autoradiographic study in the rat.
Mahteme H; Larsson B; Sundin A; Khamis H; Graf W
Eur J Cancer; 2004 Jan; 40(1):142-7. PubMed ID: 14687798
[TBL] [Abstract][Full Text] [Related]
4. [Drug distribution in gastric cancer and adjacent tissues by preoperative intraperitoneal chemotherapy with Co-fluorouracil liposome].
Li Y; Liu BW; DU WL; Song ZC; Zhao Q; Fan LQ; Yang JQ; Li QJ; Wang MX; Jiao ZK; Zhang ZD
Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):638-40. PubMed ID: 15634532
[TBL] [Abstract][Full Text] [Related]
5. Vasopressin selectively increases 5-fluorouracil uptake by colorectal liver metastases following hepatic artery bolus infusion.
Dietz DW; Casillas S; Jones SC; Milsom JW
J Surg Res; 1998 Jul; 77(2):150-6. PubMed ID: 9733602
[TBL] [Abstract][Full Text] [Related]
6. [Experimental study on 5-FU intraperitoneal injection for liver metastasis].
Kawahara H; Hirai K; Aoki T
Gan To Kagaku Ryoho; 1998 May; 25(6):881-5. PubMed ID: 9617327
[TBL] [Abstract][Full Text] [Related]
7. Effect of carcinomatosis and intraperitoneal 5-fluorouracil on peritoneal blood flow modulated by vasopressin in the rat as measured with the 133Xe-clearance technique.
Oman M; Tölli J; Naredi P; Hafström LO
Cancer Chemother Pharmacol; 2004 Sep; 54(3):213-8. PubMed ID: 15138707
[TBL] [Abstract][Full Text] [Related]
8. [Experimental study on intraperitoneal administration of 5-fluorouracil for liver metastasis in comparison with intravenous administration].
Maruyama M; Sugano N; Ebuchi M; Yuasa Y
Gan To Kagaku Ryoho; 1999 Mar; 26(4):497-502. PubMed ID: 10097746
[TBL] [Abstract][Full Text] [Related]
9. Noradrenaline improves the tumour to normal blood flow ratio and drug delivery in a model of liver metastases.
Shankar A; Loizidou M; Burnstock G; Taylor I
Br J Surg; 1999 Apr; 86(4):453-7. PubMed ID: 10215813
[TBL] [Abstract][Full Text] [Related]
10. Development of novel 5-fluorouracil carrier erythrocyte with pharmacokinetics and potent antitumor activity in mice bearing malignant ascites.
Wang GP; Guan YS; Jin XR; Jiang SS; Lu ZJ; Wu Y; Li Y; Li M; Luo F
J Gastroenterol Hepatol; 2010 May; 25(5):985-90. PubMed ID: 20546454
[TBL] [Abstract][Full Text] [Related]
11. The healing of colon anastomosis covered with fibrin glue after early postoperative intraperitoneal chemotherapy.
Kanellos I; Christoforidis E; Kanellos D; Pramateftakis MG; Sakkas L; Betsis D
Tech Coloproctol; 2006 Jul; 10(2):115-20. PubMed ID: 16773289
[TBL] [Abstract][Full Text] [Related]
12. Phase I/II trial of intraperitoneal 5-Fluorouracil with and without intravenous vasopressin in non-resectable pancreas cancer.
Oman M; Lundqvist S; Gustavsson B; Hafström LO; Naredi P
Cancer Chemother Pharmacol; 2005 Dec; 56(6):603-9. PubMed ID: 16047145
[TBL] [Abstract][Full Text] [Related]
13. Organ distribution of 5-fluorouracil loaded gelatine microspheres in mice.
Hao X; Cheng G; Zou M; Sun J; Cui F
Pharmazie; 2004 Sep; 59(9):709-12. PubMed ID: 15497754
[TBL] [Abstract][Full Text] [Related]
14. Microprocessor-controlled iontophoretic drug delivery of 5-fluorouracil: pharmacodynamic and pharmacokinetic study.
Chandrashekar NS; Shobha Rani RH
J BUON; 2007; 12(4):529-34. PubMed ID: 18067212
[TBL] [Abstract][Full Text] [Related]
15. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
Ho DH; Pazdur R; Covington W; Brown N; Huo YY; Lassere Y; Kuritani J
Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123
[TBL] [Abstract][Full Text] [Related]
16. A study to evaluate the pharmacokinetics of oral 5-fluorouracil and eniluracil after concurrent administration to patients with refractory solid tumours and varying degrees of renal impairment (FUMA1005).
O'Donnell A; Punt CJ; Judson I; Van Maanen L; Suttle AB; Ertel P; Beale P
Cancer Chemother Pharmacol; 2003 Jan; 51(1):58-66. PubMed ID: 12497207
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin.
Koppe MJ; Bleichrodt RP; Soede AC; Verhofstad AA; Goldenberg DM; Oyen WJ; Boerman OC
J Nucl Med; 2004 Jul; 45(7):1224-32. PubMed ID: 15235070
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacokinetic comparison of intraperitoneal and intravenous 5-Fu administration].
Qing SH
Zhonghua Zhong Liu Za Zhi; 1991 Sep; 13(5):340-2. PubMed ID: 1782844
[TBL] [Abstract][Full Text] [Related]
19. Healing of colon anastomoses covered with fibrin glue after immediate postoperative intraperitoneal administration of 5-fluorouracil.
Kanellos I; Mantzoros I; Demetriades H; Kalfadis S; Kelpis T; Sakkas L; Betsis D
Dis Colon Rectum; 2004 Apr; 47(4):510-5. PubMed ID: 14978614
[TBL] [Abstract][Full Text] [Related]
20. Effect of IGF-I on healing of colonic anastomoses in rats under 5-FU treatment.
Zacharakis E; Demetriades H; Pramateftakis MG; Lambrou I; Zacharakis E; Zaraboukas T; Koliakos G; Kanellos I; Betsis D
J Surg Res; 2008 Jan; 144(1):138-44. PubMed ID: 17640667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
